Edgestream Partners L.P. lessened its position in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 36.2% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 66,942 shares of the biopharmaceutical company’s stock after selling 37,986 shares during the period. Edgestream Partners L.P.’s holdings in Royalty Pharma were worth [...]